DIalysis Symptom COntrol-Restless Legs Syndrome Trial

NCT03806530 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

52

Enrollment

OTHER

Sponsor class

Conditions

End Stage Renal Disease
Restless Legs Syndrome

Interventions

DRUG: Gabapentin
DRUG: Ropinirole
DRUG: Placebo Gabapentin
DRUG: Placebo Ropinirole

Sponsor

Population Health Research Institute